Heterocyclic compound and pharmaceutical composition comprising same

The present invention relates to a novel heterocyclic compound capable of suppressing activity of cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same as an active ingredient. The heterocyclic compound according to the present invention and a pharmaceutically acceptable...

Full description

Saved in:
Bibliographic Details
Main Authors Park, Changmin, Oh, Byungkyu, Min, Changhee, Kim, Yongeun
Format Patent
LanguageEnglish
Published 29.09.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel heterocyclic compound capable of suppressing activity of cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same as an active ingredient. The heterocyclic compound according to the present invention and a pharmaceutically acceptable salt thereof can be effectively used in treatment or prevention of cancers, degenerative brain diseases, etc.
Bibliography:Application Number: NZ20160734084